Bill Gates Pledges Another $1.2B To Help Wipe This Disease From The Face Of The Earth
Microsoft Corporation (NASDAQ: MSFT) co-founder Bill Gates says he remains committed to the eradication of polio with
Analyst Cuts Price On Travere Therapeutics Citing Expected Delayed PDUFA
Travere Therapeutics Inc (NASDAQ:TVTX) expects the November 17 PDUFA date for accelerated approval of lead drug sparsentan in IgA…
Analyst Attributes Two Issues For Owens & Minor’s Shares Sell Off
Owens & Minor Inc (NYSE:OMI) reduced its FY22 adjusted EPS guidance of $2.50 – $2.60 from the previous guidance of $2.85…
Relmada’s Trial Failure Removes Competitor Risk For This Company’s Newly Launched Depression Product
On Thursday, Relmada Therapeutics Inc (NASDAQ:RLMD) reported a failed Phase 3 Major Depressive Disorder monotherapy trial for its REL-1017. BofA analyst…
FDA Requests For Additional Monitoring For Travere Therapeutics’ Sparsentan In Rare Kidney Disease
Following late-cycle review interactions with the FDA, Travere Therapeutics Inc (NASDAQ:TVTX) expects the previously assigned Prescription Drug User Fee Act…
Imara Agrees To Merge With Precision Oncology Player, Shares Surge
Enliven Therapeutics Inc and Imara Inc (NASDAQ:IMRA) agreed to merge in an all-stock transaction. The combined company will focus on advancing Enliven’s…
Analyst Upgrades Biogen Citing Upcoming Conference, Competitive Readouts
Stifel upgraded Biogen Inc (NASDAQ: BIIB) from Hold to Buy, saying shares have faded since positive lecanemab data in mild Alzheimer's.
Nevro Secures FDA Nod HFX iQ Spinal Cord Stimulation System For to Personalize Pain Treatment
The FDA approved Nevro Corp’s (NYSE:NVRO) Senza HFX iQ spinal cord stimulation (SCS) system. Senza HFX iQ is the first and…
FDA Signals Shortage For Teva Pharma’s ADHD Drug Due To Manufacturing Delay
The FDA said that there was a shortage of Adderall after intermittent manufacturing delays at Teva Pharmaceutical Industries Ltd (NYSE: TEVA).